Regulating the Secondary Use of Data for Research: Arguments Against Genetic Exceptionalism
Open Access
- 20 December 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 10, 1254
- https://doi.org/10.3389/fgene.2019.01254
Abstract
As accessing, collecting, and storing personal information become increasingly easier, the secondary use of data has the potential to make healthcare research more cost and time effective. The widespread reuse of data, however, raises important ethical and policy issues, especially because of the sensitive nature of genetic and health-related information. Regulation is thus crucial to determine the conditions upon which data can be reused. In this respect, the question emerges whether it is appropriate to endorse genetic exceptionalism and grant genetic data an exceptional status with respect to secondary use requirements. Using Swiss law as a case study, it is argued that genetic exceptionalism in secondary use regulation is not justified for three reasons. First, although genetic data have particular features, also other non-genetic data can be extremely sensitive. Second, having different regulatory requirements depending on the nature of data hinders the creation of comprehensible consent forms. Third, empirical evidence about public preferences concerning data reuse suggests that exceptional protection for genetic data alone is not justified. In this sense, it is claimed that regulation concerning data reuse should treat genetic data as important, but not exceptional.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
This publication has 44 references indexed in Scilit:
- Influenza Forecasting with Google Flu TrendsPLOS ONE, 2013
- A tiered-layered-staged model for informed consent in personal genome testingEuropean Journal of Human Genetics, 2012
- Mining electronic health records: towards better research applications and clinical careNature Reviews Genetics, 2012
- Genetic risk prediction in complex diseaseHuman Molecular Genetics, 2011
- The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studiesBMC Medical Genomics, 2011
- Genomic research and wide data sharing: Views of prospective participantsGenetics in Medicine, 2010
- “Broad” consent, exceptions to consent and the question of using biological samples for research purposes different from the initial collection purposeSocial Science & Medicine (1982), 2010
- Toward a National Framework for the Secondary Use of Health Data: An American Medical Informatics Association White PaperJournal of the American Medical Informatics Association, 2007
- Consent and anonymization in research involving biobanksEMBO Reports, 2006
- Drafting the Genetic Privacy Act: Science, Policy, and Practical ConsiderationsThe Journal of Law, Medicine & Ethics, 1995